Nearly 400 Novel Medicines in Development for Infectious Diseases

America’s biopharmaceutical research companies are developing 394 new medicines for infectious diseases, according to a new report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA). 

Infectious diseases were the leading cause of death in the United States until the 1920s

WASHINGTON, D.C. (December 4, 2013) – America’s biopharmaceutical research companies are developing 394 new medicines for infectious diseases, including viral infections, bacterial infections, fungal infections and parasitic infections, according to a new report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA).

Infectious Diseases Infographic

Medicines in Development: Infectious Diseases

4,710 Clinical Trials Conducted By Massachusetts Research Centers Total Includes 491 Trials Conducted In Worcester Since 1999

                              

Research in Massachusetts

Research in Nebraska

More Than 450 Innovative Medicines in Development for Rare Diseases

WASHINGTON, D.C. (October 7, 2013) – America’s biopharmaceutical research companies are developing 452 new medicines for rare diseases, including genetic disorders, neurological conditions, infectious diseases and autoimmune disorders, according to a new report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA).

Rare Diseases - Big Impact

Medicines in Development for Rare Diseases

Pages

Subscribe to RSS - Innovation